Arnav Chhabra, PhD - Co-Founder & Head of Platform R&D
Founded
2019
Stage
Seed
Invested
2020
Status
Private
Satellite Bio is on a quest to create a better way to take on some of humankind’s most elusive diseases. It’s an audacious journey, and it’s led us to an entirely new category of regenerative medicine: Tissue Therapeutics.
Tissue Therapeutics represents a revolutionary approach to using bioengineered tissues to assist organs affected by disease, and it lies at the heart of a future pipeline of cell-based treatments designed to tackle a broad range of severe, life-threatening conditions.
Satellite Bio
FractionFraction
Faction Ventures, LLC (“Faction”) and Lightspeed Management Company, L.L.C. (“Lightspeed”) are separate businesses that operate independently of each other. Faction is a registered investment adviser under the United States Investment Advisers Act of 1940, as amended. Faction advises its own fund(s) and does not advise any Lightspeed clients, and Lightspeed does not advise Faction or any of its clients. Lightspeed and Faction are parties to an agreement pursuant to which Lightspeed holds certain interests in Faction and the fund(s) Faction manages.
